Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s

We recently discovered an inherited cancer syndrome caused by BRCA1-Associated Protein 1 (BAP1) germline mutations, with high incidence of mesothelioma, uveal melanoma and other cancers and very high penetrance by age 55. To identify families with the BAP1 cancer syndrome, we screened patients with family histories of multiple mesotheliomas and melanomas and/or multiple cancers. We identified four families that shared an identical BAP1 mutation: they lived across the US and did not appear to be related. By combining family histories, molecular genetics, and genealogical approaches, we uncovered a BAP1 cancer syndrome kindred of ~80,000 descendants with a core of 106 individuals, whose members descend from a couple born in Germany in the early 1700s who immigrated to North America. Their descendants spread throughout the country with mutation carriers affected by multiple malignancies. Our data show that, once a proband is identified, extended analyses of these kindreds, using genomic and genealogical studies to identify the most recent common ancestor, allow investigators to uncover additional branches of the family that may carry BAP1 mutations. Using this knowledge, we have identified new branches of this family carrying BAP1 mutations. We have also implemented early-detection strategies that help identify cancers at early-stage, when they can be cured (melanomas) or are more susceptible to therapy (MM and other malignancies).

[1]  S. Pastorino,et al.  Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma , 2016, Oncogene.

[2]  B. Bressac-de Paillerets,et al.  Germline BAP1 mutations predispose also to multiple basal cell carcinomas , 2015, Clinical genetics.

[3]  Arun D. Singh,et al.  Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients , 2015, Ophthalmic genetics.

[4]  M. Becich,et al.  High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  M. Mihm,et al.  BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. , 2015, Human pathology.

[6]  S. Narod,et al.  Multiple primary cancers as a guide to heritability , 2014, International journal of cancer.

[7]  Shin-Ai Lee,et al.  Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis , 2014, Nature Communications.

[8]  J. Gagné,et al.  Germline mutations in BAP1 impair its function in DNA double-strand break repair. , 2014, Cancer research.

[9]  Helen Yu,et al.  Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair , 2013, Proceedings of the National Academy of Sciences.

[10]  Brian L Browning,et al.  Detecting identity by descent and estimating genotype error rates in sequence data. , 2013, American journal of human genetics.

[11]  Jean-François Zagury,et al.  Haplotype estimation using sequencing reads. , 2013, American journal of human genetics.

[12]  M. Carbone,et al.  Asbestos is not just asbestos: an unrecognised health hazard. , 2013, The Lancet. Oncology.

[13]  Thomas Krausz,et al.  BAP1 and cancer , 2013, Nature Reviews Cancer.

[14]  David Levine,et al.  A high-performance computing toolset for relatedness and principal component analysis of SNP data , 2012, Bioinform..

[15]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[16]  H. Pass,et al.  BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs , 2012, Journal of Translational Medicine.

[17]  N. Grishin,et al.  BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.

[18]  M. Abdel-Rahman,et al.  Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers , 2011, Journal of Medical Genetics.

[19]  N. Cox,et al.  Germline BAP1 mutations predispose to malignant mesothelioma , 2011, Nature Genetics.

[20]  Ziad M. Eletr,et al.  An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression , 2011, Cell Biochemistry and Biophysics.

[21]  G. Hart,et al.  The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression , 2010, Molecular and Cellular Biology.

[22]  M. Wilm,et al.  Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB , 2010, Nature.

[23]  Erwin G. Van Meir,et al.  BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. , 2008, Cancer research.

[24]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[25]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[26]  J. Pritchard,et al.  Confounding from Cryptic Relatedness in Case-Control Association Studies , 2005, PLoS genetics.

[27]  M. Carbone,et al.  Modern Criteria to Establish Human Cancer Etiology , 2004, Cancer Research.

[28]  J. Testa,et al.  Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey , 2001, The Lancet.

[29]  K. Nackaerts,et al.  Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. , 2015, Lung cancer.

[30]  H. Pass,et al.  Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. , 2015, Carcinogenesis.